In an article published on March 1, 2023 in Life Science Leader,
Partner Ryan
Phelan discusses the recent growth in the intellectual
property space with artificial intelligence-based patent filings
addressing emerging trends, including disease indemnification and
diagnosis, drug discovery, and personalized medicine and clinical
trials. Ryan also discusses the challenges ahead for AI-based life
science and healthcare.
“AI-based life science and healthcare trends are expected
to continue, though challenges remain,” explains Ryan.
“One such challenge comes from AI's need for big data
for the production of accurate and useful AI models. While big data
is plentiful in life science and healthcare, privacy and ethical
concerns in using such data arise. In several fields, the most
useful information often can be personal medical data, which is
difficult to access for a number of regulatory reasons.”